RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice

PloS One
Wen-ping ZhouJin-Ying Zhang

Abstract

Myocyte enhancer factor-2A (MEF 2A) has been shown to be involved in atherosclerotic lesion development, but its role in preexisting lesions is still unclear. In the present study we aim to assess the role of MEF 2A in the progression of pre-existing atherosclerosis. Eighty apolipoprotein E-deficient mice (APOE KO) were randomly allocated to control, scramble and MEF 2A RNA interference (RNAi) groups, and constrictive collars were used to induce plaque formation. Six weeks after surgery, lentiviral shRNA construct was used to silence the expression of MEF 2A. Carotid plaques were harvested for analysis 4 weeks after viral vector transduction. Inflammatory gene expression in the plasma and carotid plaques was determined by using ELISAs and real-time RT-PCR. The expression level of MEF 2A was significantly reduced in plasma and plaque in the RNAi group, compared to the control and NC groups, whereas the expression level of pro-inflammatory cytokines was markedly increased. Silencing MEF 2A using lentiviral shRNA significantly reduced the plaque collagen content and fibrous cap thickness, as well as increased plaque area. However, silencing MEF 2A had no obvious effect on plaque lipid content. Lentivirus-mediated MEF 2A shRNA acce...Continue Reading

References

Jan 19, 1999·Annual Review of Cell and Developmental Biology·B L Black, E N Olson
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
Apr 13, 2000·Journal of Internal Medicine·P Libby
Feb 14, 2002·Trends in Biochemical Sciences·Timothy A McKinseyEric N Olson
Oct 22, 2004·Human Molecular Genetics·M R Krishna BhagavatulaQing Wang
Apr 21, 2005·The Journal of Clinical Investigation·David Altshuler, Joel N Hirschhorn
Apr 21, 2005·The Journal of Clinical Investigation·Li WengLen A Pennacchio
Oct 1, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuaki KajimotoNaoharu Iwai
Jan 4, 2006·The Journal of Gene Medicine·Petri I MäkinenSeppo Ylä-Herttuala
Jan 7, 2006·Gene Therapy·K V Morris, J J Rossi
Jun 21, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Yaling HanJian Kang
Dec 19, 2007·Circulation·Wolfgang LiebJeanette Erdmann
Apr 18, 2008·Nutrition Journal·Hidekatsu YanaiNorio Tada
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Jan 21, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Lung-An HsuYu-Lin Ko
May 12, 2009·The Medical Clinics of North America·Camila ManriqueJames R Sowers
Sep 12, 2009·Circulation Research·Ross C LaxtonShu Ye
Jun 16, 2010·European Journal of Clinical Investigation·Da-Peng DaiJian-Ping Cai
Feb 1, 2013·Mediators of Inflammation·Sébastien LengletFabrizio Montecucco
Feb 5, 2013·Clinical and Investigative Medicine. Médecine Clinique Et Experimentale·Hui ZhangLing Li
Mar 21, 2013·Cardiovascular Research·Changcun FangQingzhong Xiao

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
fluorescence microscopy
X-ray
ELISA
gene knockdown

Software Mentioned

Image J
Pro Plus
ImageJ
Image

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis